Familial atypical multiple melanoma syndrome (FAMMM syndrome) is an inherited disorder characterized by a predisposition to develop atypical melanomas (skin cancers) and other forms of cancer, such as pancreatic cancer and breast cancer. The severity of the syndrome can vary among individuals, making diagnosis and treatment challenging. Early diagnosis, regular skin monitoring, and a comprehensive approach to treating both primary and secondary tumors are critical to improving patient outcomes.
History of the disease and interesting historical facts
Familial atypical multiple melanoma syndrome was initially described in the late 20th century. One of the first researchers to pay attention to this condition was Dr. Frederick F. Klauster, who in 1985 presented the results of his observations of a group of melanoma patients who had a special predisposition to develop atypical forms. Detailed genetic studies conducted later established a link between mutations in the CDKN2A and CDK4 genes with the development of this syndrome, which became an important contribution to the understanding of its pathogenesis. Interestingly, in some cases, patients with FAMMM syndrome may have a family history of various types of solid tumors, which completes the complex picture of the disease.
Epidemiology
The epidemiology of familial atypical multiple melanoma syndrome shows an increased incidence in certain populations, especially among people of European descent. According to studies, the incidence of FAMMM syndrome ranges from 1:10,000 to 1:100,000 in the general population. However, in the presence of a predisposition in the family, this risk can increase to 50%. Statistics indicate that women may be more likely to suffer from melanoma and other tumors associated with this syndrome, although in men the diseases may develop more aggressively. Particular attention is drawn to regions with high levels of solar radiation, where the risk of developing melanoma is significantly higher.
Genetic predisposition to this disease
Genetic predisposition to familial atypical multiple melanoma syndrome is primarily associated with mutations in the CDKN2A and CDK4 genes. These genes play a key role in the regulation of the cell cycle and apoptosis, and their damage can lead to uncontrolled cell division, contributing to the development of tumors. Different populations have different mutation frequencies, and a frequently identified mutation variant in the CDKN2A gene can be found in up to 40% cases among FAMMM syndrome carriers. In addition, the study of other genes, such as MTAP and TERT, also makes it possible to identify additional predisposing factors, which opens new horizons in understanding the molecular mechanisms of this disease.
Risk factors for the development of this disease
There are several known risk factors that contribute to the development of familial atypical multiple melanoma syndrome:
- Solar radiation: Excessive exposure to ultraviolet (UV) rays causes DNA mutations in skin cells.
- Physical factors: Living in areas with high solar activity, low skin pigmentation (blondes and redheads), the presence of a large number of moles.
- Heredity: Having a family history of melanoma or other cancers significantly increases your risk.
- Climate conditions: People living in sunny conditions and having a high solar activity index are at greater risk.
Diagnosis of this disease
Diagnosis of familial atypical multiple melanoma syndrome includes:
- Main symptoms: Presence of atypical moles (uneven color, irregular edges and increased size).
- Laboratory tests: Genetic testing to detect mutations in the CDKN2A and CDK4 genes.
- Radiological examinations: MRI or CT to assess the metastatic process.
- Other types of diagnostics: Dermatoscopy and biopsy of atypical formations for histological analysis.
- Differential diagnosis: Other dermatological diseases such as basal cell carcinoma and squamous cell carcinoma must be excluded.
Treatment
Treatment of FAMMM syndrome involves a multifaceted approach that varies depending on the stage of the disease:
- General treatment: Regular monitoring of the skin condition and occasional biopsy of affected areas.
- Pharmacological treatment: Immunotherapy and targeted drugs such as stranatomab.
- Surgical treatment: Removal of atypical moles and metastatic formations, possibly followed by plastic surgery.
- Other treatments: Radiation therapy may be recommended in some cases for localized tumors.
List of medications used to treat this disease
Medicines used to treat atypical multiple melanoma include:
- Ipilimumab (Yervoy)
- Nivolumab (Opdivo)
- Dabrafenib (Tafinlar)
- Trametinib (Mekinist)
- Cobimetinib (Cotellic)
Disease monitoring
Monitoring of the condition of patients with FAMMM syndrome should be carried out:
- Regular dermatologist examinations every 3-6 months.
- Examinations every 6-12 months using all available diagnostic methods.
- Prognosis: With early diagnosis and adequate treatment, 5-year survival can reach 90%.
- Complications: Recurrent cases of the disease and the development of concomitant malignant tumors are possible.
Age-related features of the disease
Age-related features of the familial syndrome of atypical multiple melanoma are related to the fact that the disease most often manifests itself in young and middle-aged people (20-40 years). However, in some cases it can also manifest itself in children, especially if there are cases of FAMMM syndrome in the family. In older people, as a rule, the disease has a more invasive and aggressive nature.
Questions and Answers
- What is the heredity of this syndrome? FAMMM syndrome has an autosomal dominant inheritance pattern, meaning that the probability of passing the syndrome from parent to child is about 50%.
- How often do you need to see a dermatologist? It is recommended to undergo examinations by a dermatologist every 3-6 months, especially if you have atypical moles.
- What are the treatment options for atypical multiple melanoma? Treatment may include immunotherapy, surgery, and specialized drugs such as Ipilimumab and Nivolumab.
- What are the main symptoms of the disease? The main symptoms are atypical moles that have irregular edges, uneven color and increase in size.
- What is the influence of solar radiation on the development of the disease? Excessive exposure to UV radiation is the main risk factor for the development of FAMMM syndrome.
Advice from Dr. Oleg Korzhikov
Dr. Oleg Korzhikov recommends paying special attention to your health and skin, especially if there is a hereditary predisposition to the syndrome. Regular dermatologist examinations, use of sunscreens and general adherence to self-examination rules are important preventive measures. It is also recommended to keep a diary of your moles - record their changes in size, color and shape. If you have any doubts about the condition of your skin or changes in moles, do not delay a visit to a specialist.
